Book Building - SME
₹ - cr
₹ 0
-
₹ -
NSE - SME
-
-
-
Initial public offer consisting of fresh issue of upto 52,86,000* equity shares of face value of Rs. 10/- each fully paid for cash at a price of Rs. [*] per equity share (The Issue Price) (including a share premium of Rs. [*] per equity share) aggregating up to Rs. [*] crores (The Issue) of which upto [*] quity shares of face value of Rs. 10/- each for cash at a price of Rs. [*]/- per equity share, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (The market maker reservation portion). The issue less market maker reservation portion i.e. Issue of upto [*] equity shares of face value of Rs. 10/- each for cash at a price of Rs. [*]/- per equity share, aggregating Rs. [*] crores is hereinafter refered to as the Net Issue. The issue and the net issue will constitute [*]% and [*]% respectively of the fully diluted post issue paid up equity share capital of the company.The Face value of the equity shares is Rs. 10 each.
Setting up of a soft gel manufacturing facility. Building up of a corporate office and warehouse. Upgrading Air Handling Unit at existing manufacturing facility Unit I. Repayment/prepayment of certain secured borrowings. Funding the working capital requirements of the company. General corporate purposes.
MDC Pharmaceuticals Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Email - mdcpharma.legal@gmail.com
Website - www.mdcpharmaceutical.com